Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women-Reference-Cited by-同舟云学术

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women

Published:2024-07-24 Issue: Volume: Page:
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Bekker Linda-Gail¹^ORCID,Das Moupali¹,Abdool Karim Quarraisha¹^ORCID,Ahmed Khatija¹,Batting Joanne¹,Brumskine William¹,Gill Katherine¹,Harkoo Ishana¹,Jaggernath Manjeetha¹,Kigozi Godfrey¹,Kiwanuka Noah¹,Kotze Philip¹,Lebina Limakatso¹,Louw Cheryl E.¹,Malahleha Moelo¹,Manentsa Mmatsie¹,Mansoor Leila E.¹^ORCID,Moodley Dhayendre¹,Naicker Vimla¹,Naidoo Logashvari¹,Naidoo Megeshinee¹,Nair Gonasagrie¹,Ndlovu Nkosiphile¹,Palanee-Phillips Thesla¹,Panchia Ravindre¹,Pillay Saresha¹,Potloane Disebo¹,Selepe Pearl¹,Singh Nishanta¹,Singh Yashna¹,Spooner Elizabeth¹,Ward Amy M.¹,Zwane Zwelethu¹,Ebrahimi Ramin¹,Zhao Yang¹,Kintu Alexander¹,Deaton Chris¹,Carter Christoph C.¹,Baeten Jared M.¹,Matovu Kiweewa Flavia¹

Affiliation:

1. From the Desmond Tutu HIV Centre (L.-G.B., K.G., G.N., Y.S.) and the Department of Medicine, Vuka Research Clinic (A.M.W.), University of Cape Town, Cape Town, the Department of Epidemiology and Prevention, Centre for the AIDS Programme of Research in South Africa (Q.A.K.), Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal (I.H., L.E.M., D.M., M.N., D.P.), the Department of Obstetrics and Gynaecology, Wits Maternal, Adolescent, and Child Health Research Unit,...

Funder

Gilead Sciences

Publisher

Massachusetts Medical Society

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2407001

Reference41 articles.

1. Joint United Nations Programme on HIV/AIDS. AIDSinfo (https://aidsinfo.unaids.org).

2. Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies

3. HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women

4. AVAC. The global PrEP tracker (https://data.prepwatch.org).

5. Joint United Nations Programme on HIV/AIDS. Ending inequalities and getting on track to end AIDS by 2030 — a summary of the commitments and targets within the United Nations General Assembly’s 2021 Political Declaration on HIV and AIDS. 2022 (https://www.unaids.org/sites/default/files/media_asset/2021-political-declaration_summary-10-targets_en.pdf).

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Human T-cell Leukemia Virus capsid protein is a potential drug target;2024-09-10

2. Exploring HIV-1 Maturation: A New Frontier in Antiviral Development;Viruses;2024-09-06

3. Lenacapavir to prevent HIV infection: current prices versus estimated costs of production;Journal of Antimicrobial Chemotherapy;2024-09-03

4. Integrated PrEP and STI Services for Transgender Women in Uganda: Qualitative Findings from a Randomized Trial;AIDS and Behavior;2024-09-02

5. HIV: how close are we to a vaccine — or a cure?;Nature;2024-09-02